Cargando…
Treatment with gefitinib after erlotinib-induced liver injury: a case report
INTRODUCTION: Gefitinib and erlotinib have minor differences in their chemical structures, and thus it remains unclear whether the hepatotoxicity induced by one compound is affected by the other. The case of a patient who developed erlotinib-induced liver injury and was then treated with gefitinib w...
Autores principales: | Nakatomi, Katsumi, Nakamura, Yoichi, Tetsuya, Iida, Kohno, Shigeru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339363/ https://www.ncbi.nlm.nih.gov/pubmed/22188652 http://dx.doi.org/10.1186/1752-1947-5-593 |
Ejemplares similares
-
Successful erlotinib rechallenge after both gefitinib- and erlotinib-induced interstitial lung diseases
por: Arakawa, Nobuhito, et al.
Publicado: (2013) -
Predicting Tumor Responses to Gefitinib and Erlotinib
Publicado: (2005) -
Correction: Predicting Tumor Responses to Gefitinib and Erlotinib
Publicado: (2012) -
Successful Erlotinib Treatment for a Patient with Gefitinib-Related Hepatotoxicity and Lung Adenocarcinoma Refractory to Intermittently Administered Gefitinib
por: Nagano, Tatsuya, et al.
Publicado: (2011) -
Aspartames Alter Pharmacokinetics Parameters of Erlotinib and Gefitinib and Elevate Liver Enzymes in Wistar Rats
por: AlRasheed, Hajer, et al.
Publicado: (2022)